UPEXI, INC. current report, 10 August 2022

SEC Form 8-K Summary

Business Context and Reporting Period

Grove, Inc. filed a Form 8-K dated August 10, 2022, under Items 7.01 (Regulation FD Disclosure) and 8.01 (Other Events). The filing is not a periodic financial report and does not provide financial statements or results for a reporting period.

The request metadata identifies UPEXI, Inc., while the filing identifies the registrant as Grove, Inc.; this issuer-name discrepancy should be verified.

Key Financial Metrics

The filing does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.

Material Changes Versus Prior Period

No material financial or operational changes versus a prior comparable period are disclosed.

Guidance, Outlook, Risks, and Unusual Items

  • Chief Executive Officer Allan Marshall was scheduled to present virtually at the Sidoti & Company August Virtual Microcap Conference on August 17, 2022, at 3:15 p.m. Eastern Time.
  • The filing includes the related press release and investor presentation as Exhibits 99.1 and 99.2.
  • The filing contains standard forward-looking statement cautionary language covering growth strategy, financial results, product development, market data, assumptions, and other known and unknown risks.
  • No specific financial guidance, forecast, contingency, litigation matter, financing, or unusual accounting item is disclosed in the provided text.
  • The Regulation FD and Other Events information is furnished rather than filed and is not incorporated by reference into other filings except by specific reference.

Investor Verification Items

  • Verify whether the filing pertains to Grove, Inc. or UPEXI, Inc., including any name change or corporate relationship.
  • Review Exhibits 99.1 and 99.2 for management commentary, business plans, financial information, and any guidance not included in the filing body.
  • Confirm whether the scheduled investor presentation occurred and whether subsequent filings provided updated information.
  • Assess the forward-looking statements against the company’s stated risk factors and later reported results.